Literature DB >> 1987620

Nonpalpable prostate cancer: detection with MR imaging.

H B Carter1, R F Brem, C M Tempany, A Yang, J I Epstein, P C Walsh, E A Zerhouni.   

Abstract

The pathologic specimens and magnetic resonance (MR) images of 53 patients with clinically palpable prostate cancer confined to one lobe were studied to evaluate the ability of MR imaging to depict clinically nonpalpable prostate cancer. All patients had undergone imaging with a 1.5-T imager with T1- and T2-weighted sequences in both axial and sagittal planes before undergoing radical retropubic prostatectomy. At pathologic examination, only the palpable tumor was present in 30 of the 53 patients (57%), and 33 unsuspected tumors were present in an area distinct from the palpable tumor in 23 of the patients (43%). MR imaging successfully depicted 51 palpable tumors for a sensitivity of 96% and 19 of the 33 unsuspected tumors for a sensitivity of 58%. The sensitivity of MR imaging in the detection of nonpalpable, posteriorly located tumors was greater than for those located anteriorly (85% vs 15%). MR imaging was false-positive for nonpalpable tumor in 17 of 30 patients for a specificity of 43%. On the basis of these data, MR imaging has greater sensitivity in the depiction of posteriorly located cancer and is limited by a high false-positive rate in the depiction of nonpalpable tumors.

Entities:  

Mesh:

Year:  1991        PMID: 1987620     DOI: 10.1148/radiology.178.2.1987620

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Focal therapy: a new paradigm for the treatment of prostate cancer.

Authors:  Basir Tareen; Guilherme Godoy; Samir S Taneja
Journal:  Rev Urol       Date:  2009

Review 2.  Is it time to consider a role for MRI before prostate biopsy?

Authors:  Hashim U Ahmed; Alex Kirkham; Manit Arya; Rowland Illing; Alex Freeman; Clare Allen; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

Review 3.  Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.

Authors:  Daniel J Lee; Hashim U Ahmed; Caroline M Moore; Mark Emberton; Behfar Ehdaie
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

4.  Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification.

Authors:  Yan Bai; Mei-Yun Wang; Yan-Hong Han; She-Wei Dou; Qing Lin; Ying Guo; Wei Li; De-Gang Ding; Jian-Ping Dai; Wei Qin; Da-Peng Shi; Jie Tian; Yong-Ming Dai
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

5.  Prostate cancer: added value of subtraction dynamic imaging in 3T magnetic resonance imaging with a phased-array body coil.

Authors:  Jeong-Sik Yu; Jae-Joon Chung; Soon Won Hong; Byung Ha Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.